Blue Jet Healthcare IPO opens tomorrow: GMP, issue details, 10 key things to know
Blue Jet Healthcare IPO raised a capital of ₹252.08 crore through an anchor book process, where 22 investors took part in the anchor book offering, on Monday, October 23. Blue Jet Healthcare is an intermediary company that provides pharmaceutical and healthcare ingredients. In India, Blue Jet Healthcare was the pioneer in producing saccharin and its derivatives, or artificial sweeteners.
Blue Jet Healthcare branched out into contrast medium intermediates, which are utilised in MRI and CT examinations. The company primarily sells products in three categories: active pharmaceutical components and pharma intermediates, high-intensity sweeteners, and contrast media intermediates. Blue Jet Healthcare IPO floor price is 164.50 times the face value of the equity shares and the cap price is 173 times the face value of the equity shares.
The price to earning ratio based on diluted earnings per share (EPS) for fisal 2023 at the floor price is 35.64 times at the cap price is 37.49 times. There are no listed companies in India that engage in a business similar to that of Blue Jet Healthcare, said the company in its Red Herring Prospectus (RHP). A few major risks that the company has identified in its Red Herring Prospectus (RHP) include that it depends on selling its products to a small number of important clients.
Read more on livemint.com
